NCT03937622 (NONSTOP) is a clinical trial of 17 items questionaire in Oxygen Toxicity, sponsored by Hannover Medical School.

Who is sponsoring NCT03937622?

NCT03937622 is sponsored by Hannover Medical School.

What drugs are being tested in NCT03937622?

Interventions in NCT03937622: 17 items questionaire.

What condition does NCT03937622 study?

NCT03937622 studies Oxygen Toxicity.

Is NCT03937622 still recruiting?

NCT03937622 is currently status unknown. Last updated 7 August 2019.

Last reviewed 2019-08-07 · How we verify

NCT03937622: NONSTOP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Northern Survey on Therapeutic Oxygen Prescription

Status unknown Last updated 7 August 2019

What this trial tests

trial testing 17 items questionaire in Oxygen Toxicity in 500 participants. Status unknown.

Timeline

2 July 2019

Primary endpoint
20 June 2021

20 September 2021

Quick facts

Lead sponsor	Hannover Medical School
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	2 July 2019
Primary completion	20 June 2021
Estimated completion	20 September 2021
Sites	2 locations across Germany

Drugs / interventions tested

17 items questionaire

Conditions studied

Oxygen Toxicity — all drugs for Oxygen Toxicity →

Sponsor

Hannover Medical School

Who can join

18 and older, any sex, with Oxygen Toxicity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective multicenter observational trial. Included patients and attending physician complete a standardized questionnaire.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Quality of Domiciliary Oxygen Therapy in Adults with Chronic Respiratory Diseases- Results of a Multicenter Cross-Sectional Study in Germany.
Gottlieb J, Schrepper H, Valtin C, Welte T, et al · · 2022 · cited 1× · PMID 35125132 · DOI 10.3238/arztebl.m2021.0294

Verify or expand the search:

Other recruiting trials for Oxygen Toxicity

Currently open trials in the same condition.

NCT05761756 — Oxygen Toxicity: Mechanisms in Humans · NA · recruiting
NCT05737407 — Lung Ultrasound Guided Choice of Best Positive End-Expiratory Pressure in Neonatal Anesthesia · NA · recruiting

Other Hannover Medical School trials

Trials by the same sponsor.

NCT07384039 — Exercise Training in Patients With Myeloproliferative Neoplasms · NA · not yet recruiting
NCT06740747 — Intermittent Theta-Burst Stimulation to Improve Negative Symptoms and Cognition in Schizophrenia · NA · recruiting
NCT06795516 — Observational Study on the Clinical Use of ex Vivo Lung Perfusion (XPS™) for Lung Transplantation · terminated
NCT06603311 — Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of · NA · active not recruiting
NCT06493006 — Promoting Sustainable and Active Mobility Among Employees and Students · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03937622 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hannover Medical School
Last refreshed: 7 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing